Mergers News
Thursday, August 4, 2016
BRIEF-Juniper Pharmaceuticals Q2 loss per share $0.16
* Juniper Pharmaceuticals reports second quarter 2016
financial results
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment